Our results showed significantly higher H3K9la levels in KRAS-mutant CRC tissues compared to KRAS wild-type CRC tissues, and in CRC tissues compared to normal colon tissues (Fig. 1H–J). This evidence concerns the gene KRAS and colorectal carcinoma.